|
US2019008779A1
|
|
Gemcabene compositions and methods of use thereof
|
|
US2018250251A1
|
|
Treatment of Patients with Familial Hypercholesterolemia on Lipid-Lowering Therapy
|
|
KR20200054910A
|
|
Gemcarbine, pharmaceutically acceptable salts, compositions and methods of use thereof
|
|
WO2018165120A1
|
|
Effect of carboxyalkylethers on obesity symptoms and lipodystropy
|
|
US2017246133A1
|
|
Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapy
|
|
MX2018010096A
|
|
Treatment of patients with homozygous familial hypercholesterolemia on lipid lowering therapy.
|
|
AU2016349634A1
|
|
Treatment of mixed dyslipidemia
|
|
CN107108442A
|
|
For preparing α, the method and intermediate of the dioxane ether of ω dicarboxyl acid blockeds
|
|
AU2015202580A1
|
|
Gemcabene and derivatives for treating pancreatitis
|
|
CN110025608A
|
|
The method for reducing risk of cardiovascular diseases
|
|
EP2658536A1
|
|
Gemcabene and derivatives for treating pancreatitis
|
